Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind double-dummy multicenter trial of Taisi capsules in mild to moderate Alzheimer's disease
CTR20150412Phase 3Active
- Sponsor
- Xuanwu Hospital
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil in Alzheimer's disease (AD), sponsored by Xuanwu Hospital. Started Aug 2021; status: active.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on CTR20150412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150412.